Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK.

  1. Inicio
  2. »
  3. Sin categoría
  4. »
  5. Risk of venous thromboembolism among users of different anti-osteoporosis drugs:...
Patrocinadores de la web
Lilly
Angelini
Laboratorios Rubió
Grupo Italfármaco
UCB-Pharma
Theramex
Stada
Gedeon Richter
Kyowa Kirin
Amgen
Gebro
Faes Farma
Meiji Pharma